Janux Therapeutics is a clinical-stage biotech company specializing in immunotherapies designed to trigger tumor-specific immune responses without harming healthy tissue. Utilizing its platform masking technology, Janux develops novel drug candidates that address the limitations of traditional T cell engagers. The company has earned recognition as a Great Place To Work Certificationā¢, highlighting its commitment to fostering an innovative and supportive work environment.
Janux Therapeutics is seeking a Clinical Biomarker Lead to join our Translational group and contribute to the end-to-end planning and execution of clinical biomarker strategy for our early-stage clinical programs.
Janux Therapeutics is a clinical-stage biotech company specializing in immunotherapies designed to trigger tumor-specific immune responses without harming healthy tissue. Utilizing its platform masking technology, Janux develops novel drug candidates that address the limitations of traditional T cell engagers. The company has earned recognition as a Great Place To Work Certificationā¢, highlighting its commitment to fostering an innovative and supportive work environment.
Boehringer Ingelheim